PTP — Pentixapharm Holding AG Share Price
0.000.00%
Last trade - 00:00- €71.99m
- €48.76m
- €6.82m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.46 | ||
| Price to Tang. Book | 5.12 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 10.56 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -31.81% | ||
| Return on Equity | -51.98% | ||
| Operating Margin | -248.93% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | n/a | n/a | n/a | n/a | 6.82 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Pentixapharm Holding AG is a Germany-based clinical-stage radiopharmaceutical development company. The Company focuses on the development of radiopharmaceuticals for various therapeutic areas, as well as for the diagnosis and therapy (theranostics) of blood cancer and others. It is also engaged in holding activities and is also involved in the research and development of drugs for hematological and solid cancers, as well as cardiovascular, endocrine and inflammatory diseases.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- January 1st, 1970
- Public Since
- October 3rd, 2024
- No. of Employees
- 71
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- XETRA
- Shares in Issue
- 24,783,048
- Address
- Robert-Roessle-Strasse 10, BERLIN, 13125
- Web
- https://www.pentixapharm.com/
- Phone
- +49 3094893220
- Contact
- Phillip Eckert
- Auditors
- Forvis Mazars Audit GmbH Wirtschaftsprüfungsgesellschaft
Upcoming Events for PTP
Similar to PTP
FAQ
What is the Pentixapharm Holding AG share price?
As of Today at 04:35 UTC, shares in Pentixapharm Holding AG are trading at €2.91. This share price information is delayed by 15 minutes.
How has the Pentixapharm Holding AG share price performed this year?
Shares in Pentixapharm Holding AG last closed at €2.91 and the price had moved by over the past 365 days. In terms of relative price strength the Pentixapharm Holding AG share price has matched the FTSE Global All Cap Index by over the past year.
What are the analyst and broker recommendations for Pentixapharm Holding AG?
The overall consensus recommendation for Pentixapharm Holding AG is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Pentixapharm Holding AG dividend yield?
Pentixapharm Holding AG does not currently pay a dividend.
Does Pentixapharm Holding AG pay a dividend?
Pentixapharm Holding AG does not currently pay a dividend.
When does Pentixapharm Holding AG next pay dividends?
Pentixapharm Holding AG does not currently pay a dividend.
How do I buy Pentixapharm Holding AG shares?
To buy shares in Pentixapharm Holding AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Pentixapharm Holding AG?
As of the previous close price of €2.91, shares in Pentixapharm Holding AG had a market capitalisation of €71.99m.
Where are Pentixapharm Holding AG shares listed?
Here are the trading details for Pentixapharm Holding AG:
- Country of listing: Germany
- Exchange: GER
- Ticker Symbol: PTP
What kind of share is Pentixapharm Holding AG?
Based on an overall assessment of its quality, value and momentum Pentixapharm Holding AG is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Pentixapharm Holding AG share price forecast for 2025?
The analyst consensus target price for shares in Pentixapharm Holding AG is €11.70. That is 302.75% above the last closing price of €2.91.
Analysts covering Pentixapharm Holding AG currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreWhat is the trend in the Pentixapharm Holding AG share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Pentixapharm Holding AG. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -18.04%.
As of the last closing price of €2.91, shares in Pentixapharm Holding AG were trading -11.63% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Pentixapharm Holding AG PE Ratio?
The Pentixapharm Holding AG PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €2.91.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Pentixapharm Holding AG?
We do not have data on Pentixapharm Holding AG's directors